Skip to content

Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia

Phenylephrine Prophylaxis for Postspinal Anesthesia Hypotension in Parturients With Preeclampsia Undergoing Cesarean Section: a Randomized, Placebo-controlled Dose-finding Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04576663
Enrollment
95
Registered
2020-10-06
Start date
2023-10-01
Completion date
2025-09-21
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse Effect

Keywords

Phenylephrine, Postspinal anesthesia hypotension, Preeclampsia, Cesarean section, Dose-finding

Brief summary

The purpose of this study is to investigate the suitable infusion dose of phenylephrine for prophylaxis against postspinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Detailed description

Preeclampsia, which affects 5% to 7% of parturients, is a significant cause of maternal and neonatal morbidity and mortality. Because of constricted myometrial spiral arteries with exaggerated vasomotor responsiveness, though blood pressure in parturients with preeclampsia are apparently higher than healthy parturients, placental hypoperfusion is more common. Spinal anesthesia is still the preferred mode of anesthesia in parturients with preeclampsia for cesarean section. In preeclampsia parturients, spinal anesthesia improve intervillous blood flow (provided that hypotension is avoided) which contribute to increase placental perfusion. Even so, 17-26% parturients with preeclampsia experienced postspinal anesthesia hypotension due to the extensive sympathetic block that occurred with spinal anesthesia. Practical guidelines for obstetric anesthesia from the American Society of Anesthesiologists and an international consensus statement on the management of hypotension with vasopressors indicate either IV ephedrine or phenylephrine may be used to correct hypotension. But the suitable infusion dose of phenylephrine in parturients with preeclampsia is still unknown. The purpose of this study is to investigate the suitable infusion dose of phenylephrine for prophylaxis against post-spinal anesthesia hypotension in parturients with preeclampsia undergoing cesarean section.

Interventions

DRUGNormal saline

Normal saline infusion simultaneous with subarachnoid block

DRUGPhenylephrine

Different infusion dose of phenylephrine simultaneous with subarachnoid block

Sponsors

General Hospital of Ningxia Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* 18-45 years * Primipara or multipara * Singleton pregnancy ≥32 weeks * American Society of Anesthesiologists physical status classification II to III * Scheduled for cesarean section under spinal anesthesia

Exclusion criteria

* Baseline blood pressure ≥180 mmHg * Body height \< 150 cm * Body weight \> 100 kg or body mass index (BMI) ≥ 40 kg/m2 * Eclampsia or chronic hypertension * Hemoglobin \< 7g/dl * Fetal distress, or known fetal developmental anomaly

Design outcomes

Primary

MeasureTime frameDescription
The incidence of post-spinal anesthesia hypotension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \< 80% of the baseline

Secondary

MeasureTime frameDescription
Overall stability of heart rate control versus baseline1-15 minutes after spinal anesthesiaEvaluated by performance error (PE)
The incidence of severe post-spinal anesthesia hypotension1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \< 60% of the baseline
The incidence of nausea and vomiting1-15 minutes after spinal anesthesiaPresence of nausea and vomiting in patients after spinal anesthesia
The incidence of bradycardia1-15 minutes after spinal anesthesiaHeart rate \< 60 beats/min
Overall stability of systolic blood pressure control versus baseline1-15 minutes after spinal anesthesiaEvaluated by performance error (PE)
pHImmediately after deliveryFrom umbilical arterial blood gases.
Partial pressure of oxygenImmediately after deliveryFrom umbilical arterial blood gases.
Base excessImmediately after deliveryFrom umbilical arterial blood gases.
APGAR score1 min after deliveryA= Appearance P=Pulse G=Grimace A=Attitude R=Respiration
The incidence of hypertension.1-15 minutes after spinal anesthesiaSystolic blood pressure (SBP) \>120% of the baseline.

Contacts

Primary ContactXinli Ni, Dr.
xinlini6@nyfy.com.cn86-951-674-3252
Backup ContactYi Chen, M.D.
czzyxgp@163.com86-951-674-3252

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026